Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Apr. 02, 2016	Mar. 28, 2015	Jul. 02, 2016	Jun. 27, 2015
Revenues:
Product sales	$ 3,934,995	$ 5,635,889	$ 9,150,612	$ 10,883,901
Research and development under cooperative agreement				42,254
Total revenues	3,934,995	5,635,889	9,150,612	10,926,155
Cost of product sales	3,374,078	4,336,853	7,458,138	8,456,784
Cost of research and development under cooperative agreement				34,970
Gross Margin	560,917	1,299,036	1,692,474	2,434,401
Selling, general, and administrative	892,477	1,112,295	1,800,646	2,125,133
Operating income (loss)	(331,560)	186,741	(108,172)	309,268
Interest income (expense), net	2,722	851	6,462	851
Net income (loss) before income tax expense (benefit)	(328,838)	187,652	(101,710)	310,119
Income tax expense (benefit)	(70,100)	73,760	(40,100)	122,500
Net income (loss)	$ (258,738)	$ 113,832	$ (61,610)	$ 187,619
Net income (loss) per basic common share	$ (0.02)	$ 0.01	$ (0.00)	$ 0.01
Weighted average number of basic common shares outstanding	13,200,269	13,178,297	13,199,210	13,162,984
Net income (loss) per diluted common share	$ (0.02)	$ 0.01	$ (0.00)	$ 0.01
Weighted average number of diluted common shares outstanding	13,200,269	13,627,346	13,199,210	13,679,355